61.7
Protalix BioTherapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
44.9
FY23:
69.9
FY24:
60.1
FY25:
66.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
12.0
FY22:
10.9
FY23:
14.5
FY24:
13.3
FY25:
15.7
Total assets
Change from FY21 to FY25
millions USD
FY21:
73.7
FY22:
55.8
FY23:
84.4
FY24:
73.4
FY25:
82.3
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
33.2
FY22:
32.4
FY23:
45.5
FY24:
25.6
FY25:
26.5
(negative)
Change from FY21 to FY25
millions USD
FY21:
46.5
FY22:
34.0
FY23:
5.34
FY24:
4.59
FY25:
7.60
(positive)
Change from FY21 to FY25
millions USD
FY21:
−6.04
FY22:
−10.6
FY23:
33.6
FY24:
43.2
FY25:
48.2
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
73.7
FY22:
55.8
FY23:
84.4
FY24:
73.4
FY25:
82.3
All amounts in millions USD